Telomir Pharmaceuticals Inc. logo

Telomir Pharmaceuticals Inc. (TELO)

Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
1. 23
+0.08
+6.9565%
$
36.44M Market Cap
- P/E Ratio
- Div Yield
65,506 Volume
- Eps
$ 1.15
Previous Close
Investors:
Add Transaction
Day Range
1.15 1.23
Year Range
0.89 2.19
Want to track TELO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Telomir Pharmaceuticals Inc. (TELO) Statistics

Valuation metrics

Market Cap 36.44M
Enterprise value 34.18M
Trailing P/E (ttm) -3.91
Forward P/E -
PEG ratio -0.22
Price/Sales (ttm) -
Price/Book (mrq) 7.97
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.71

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 82K
Average volume (90 days) 168.91K

Price summary

52-Week low 0.89
52-Week high 2.19
Beta -
50-Day moving average 1.24
200-Day moving average 1.29

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -1.59%
Return on equity -2.01%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.27
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.16
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 7%
Book value per share (mrq) 0.14

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -